Immunocore Holdings plc
IMCRNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $1.59B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $27.50$40.72
- Volume (live)
- -
- Avg. volume (3M)
- 485.10K
Immunocore Holdings (IMCR) Stock Price & Financial Analysis
Immunocore Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $30.95 - $31.74 |
|---|---|
| 52-Week High | $40.72 |
| 52-Week Low | $27.50 |
| Open | $31.32 |
| Volume (last close) | 197.93K |
| Average Volume (3M) | 485.10K |
| Revenue (TTM) | 403.72M |
|---|---|
| Net Income (TTM) | -10.29M |
| Free Cash Flow (TTM) | -41.13M |
| EPS (TTM) | −$0.20 |
| Profit Margin | -2.55% |
| Operating Margin | -4.33% |
| Return on Equity (ROE) | -2.45% |
| Debt to Equity | 1.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.59B |
|---|---|
| Shares Outstanding | 50.97M |
| Price to Sales (P/S) | 3.95 |
| Price to Book (P/B) | 3.80 |
| EV/EBITDA | 156.50 |
| 50-Day MA | $32.94 |
|---|---|
| 200-Day MA | $31.82 |
| 1-Year Change | +1.65% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Immunocore Holdings at a Glance
As of the Oct 26, 2026 close, Immunocore Holdings (IMCR) has a market capitalization of $1.59B. The stock trades at 4.0× sales. Over the trailing twelve months it lost $10.29M on revenue of $403.72M and burned $41.13M of free cash flow. Revenue grew 20.9% year over year.
As of its latest reported balance sheet, it holds $484.92M in cash and securities against $434.96M of debt, a net cash position of $49.96M.
Immunocore Holdings does not currently pay a dividend.
The share price is up 1.6% over the past year. At $31.28 (the Oct 26, 2026 close) it sits within its 52-week range of $27.50 to $40.72, below its 200-day moving average of $31.82.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $62.83, 100.9% above the Oct 26, 2026 close.
Frequently Asked Questions About Immunocore Holdings
What is the current stock price for IMCR?
As of the Oct 26, 2026 close, IMCR stock trades at $31.28. The 52-week range is $27.50–$40.72, with a day range of $30.95–$31.74.
What is the P/E ratio for IMCR?
The P/E ratio (Price-to-Earnings) for IMCR is shown in the Key Statistics section. This valuation metric helps compare Immunocore Holdings plc to industry peers.
Does IMCR pay dividends?
Immunocore Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMCR?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for IMCR is Buy. The average 12-month price target is $62.83, a 100.9% upside from the Oct 26, 2026 close of $31.28.
What is the market cap of IMCR?
As of the Oct 26, 2026 close, Immunocore Holdings's market capitalization is $1.59B, classifying it as a small-cap company. Immunocore Holdings operates in the Healthcare sector within the Biotechnology industry.